HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group-Reference-Cited by-同舟云学术

HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group

Published:2004-01 Issue:1 Volume:15 Page:104-112
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Camilleri-Broët S.,Hardy-Bessard A.C.,Le Tourneau A.,Paraiso D.,Levrel O.,Leduc B.,Bain S.,Orfeuvre H.,Audouin J.,Pujade-Lauraine E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/1/104/333025/mdh021.pdf

Reference33 articles.

1. A prognostic model for ovarian cancer;Clark;Br J Cancer,2001

2. Cloning the chromosomal breakpoint of t(14;18) human lymphomas clustering around JH on chromosome 14 and near a transcriptional unit on chromosome 18;Bakhshi;Cell,1985

3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1987

4. When is a tumor marker ready for prime time? A case study of HER-2 as a predictive factor in breast cancer;Yamauchi;J Clin Oncol,2001

5. Duvillard et al. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group;Vacher-Lavenu;Bull Cancer,1993

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the genetic landscape: high frequency of pik3ca mutation in luminal a and b breast cancer within the Indonesian population;2024-06-03

2. Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer;Journal of Experimental & Clinical Cancer Research;2024-02-26

3. A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers;Onco;2023-05-26

4. New Directions for Epigenetics: Application of Engineered DNA-binding Molecules to Locus-specific Epigenetic Research;Handbook of Epigenetics;2023

5. Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer;BMC Cancer;2022-11-12